Analyzing...
Loading company...
“mid teens around 15 to 16%”
“guidance of 20% plus on EBITDA”
“EBITDA was stronger than ever at INR $6.”
Historical valuation data not available.
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Anthem Biosciences Limited has informed the Exchange about Schedule of meet
Anthem Biosciences Limited has informed the Exchange about Transcript
Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication pertaining to Audited Consolidated and Standalone Financial Results of the Company for the Quarter and year end...
Anthem Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Anthem Biosciences Limited hereby informs the Exchange of the First Amendment to the Loan Agreement dated April 15, 2024, entered into with Neaonathem Lifesciences Private Limited (the Wholly Owned Su...
Anthem Biosciences Limited has informed the Exchange about Transcript
Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publication
Submission of Press Release for the Financial Results for the quarter and nine months ended December 31, 2025 in machine readable format.
Submission of Audio recordings of Earnings Call for the quarter and nine months ended December 31, 2025
Allotment of 1,03,800 equity shares, of face value Rs. 2 each, pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024
Revised press release for the financial results for the quarter and nine months ended December 31, 2025 due to inadvertent missing out on the complete press release.
Press release for the financial results for the quarter and nine months ended December 31, 2025.
Anthem Biosciences Limited has informed the Exchange about Investor Presentation
Anthem Biosciences Limited has submitted to the Exchange, the financial results for the quarter and nine months ended December 31, 2025.
Anthem Biosciences Limited has informed the Exchange about Schedule of meet